4.3 Article

Traumatic Brain Injury Biomarkers, Simulations and Kinetics

Related references

Note: Only part of the references are listed.
Review Neurosciences

A Literature Review of Traumatic Brain Injury Biomarkers

Hazem S. Ghaith et al.

Summary: Research into TBI biomarkers has accelerated in the past decade, but there is still a need to develop novel biomarkers entirely correlating with TBI pathologies; extracellular vesicles and miRNA are considered as promising candidates to overcome the limitations of traditional blood and CSF assays.

MOLECULAR NEUROBIOLOGY (2022)

Review Chemistry, Analytical

The Current State of Traumatic Brain Injury Biomarker Measurement Methods

Alyse D. Krausz et al.

Summary: This review discusses devices designed to measure TBI protein biomarkers, evaluates associated challenges, and suggests future research directions to promote translation of these devices to clinical use.

BIOSENSORS-BASEL (2021)

Article Critical Care Medicine

High-Sensitivity C-Reactive Protein Is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI Study

Linda B. Xu et al.

Summary: The study found that hsCRP levels in TBI patients and orthopedic trauma controls rose between days 1 and 5, then fell within 2 weeks but remained higher compared to healthy controls. Within the first two weeks, hsCRP was significantly higher in patients with death/severe disability compared to those with moderate disability/good recovery, with the highest AUC at 2 weeks.

JOURNAL OF NEUROTRAUMA (2021)

Article Multidisciplinary Sciences

Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury

Spencer Flynn et al.

Summary: The study found that blood-derived EV concentrations of GFAP and NfL are higher in TBI patients compared to controls even 1 year after injury, and are related to injury severity and poor recovery outcomes, suggesting that TBIs alter the activity of these biomarkers, likely contributing to individual variability in recovery.

SCIENTIFIC REPORTS (2021)

Article Psychiatry

Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration

Inger Hellerhoff et al.

Summary: This study investigated serum levels of NF-L, tau protein, and GFAP in AN patients undergoing weight restoration, revealing higher levels of all three in acutely underweight AN patients compared to healthy controls. After short-term partial weight restoration, a decrease in NF-L and GFAP levels but not in tau protein levels was observed, indicating ongoing neuronal and astroglial injury during the underweight phase of AN. This suggests only partial restoration of neuronal and astroglial integrity upon weight gain after initial AN-associated cell damage processes.

TRANSLATIONAL PSYCHIATRY (2021)

Article Biotechnology & Applied Microbiology

Cyclic Damage Accumulation in the Femoral Constructs Made With Cephalomedullary Nails

Farah Hamandi et al.

Summary: The study evaluates the risk of peri-prosthetic fracture in constructs made with cephalomedullary nails, suggesting that short titanium nails can reduce the risk. Gender and age should be taken into consideration when selecting implants.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Review Neurosciences

Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies

Aidong Yuan et al.

Summary: Neurofilament proteins serve as important biomarkers of neurodegeneration and neuronal injury, reflecting neuronal damage and degeneration across various neurological diseases. Measuring NfP levels in cerebrospinal fluid and blood can track disease progression, assess treatment responses, and offer novel insights into a wide range of neurological disorders in the field of neurology.

FRONTIERS IN NEUROSCIENCE (2021)

Article Neurosciences

Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrier

Maxwell Eisenbaum et al.

Summary: The study reveals that the elimination of tau in the brain decreases following head trauma, potentially due to reduced caveolin-1 mediated tau efflux at the blood-brain barrier. Additionally, decreased expression of Mfsd2a and caveolin-1 in the cerebrovasculature post-injury leads to the accumulation of tau species in the brain.

FLUIDS AND BARRIERS OF THE CNS (2021)

Article Clinical Neurology

One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury

Gerard Janez Brett Clarke et al.

Summary: The study showed that GFAP and tau levels were highest in the acute phase, while NFL peaked at 2 weeks and 3 months in patients with mTBI. Patients with concomitant other somatic injuries had the most significant elevations in biomarker levels, and were more likely to be victims of traffic accidents and violence. Acute GFAP concentrations displayed the highest discriminability between patients and controls.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project

Michael L. Alosco et al.

Summary: The DIAGNOSE CTE Research Project aims to develop biomarkers for CTE, characterize its clinical presentation, validate diagnostic criteria, study risk factors, and share resources. With 240 male participants enrolled and baseline evaluations completed, the study is expected to contribute significantly to CTE research.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Clinical Neurology

A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury

Sima Azizi et al.

Summary: Traumatic brain injury (TBI) poses a significant burden on the economy and society, especially in the diagnosis and prognosis of mild TBI. Biomarkers play a crucial role in analyzing the brain condition after TBI.

FRONTIERS IN NEUROLOGY (2021)

Review Oncology

Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues

Daniel B. Hier et al.

Summary: Unresolved issues related to blood biomarkers after mild traumatic brain injury (mTBI) are mainly focused on the pathways of biomarkers entering and exiting the blood, the kinetics of blood biomarkers, and the predictive capacity of blood biomarkers after mTBI. Further research is needed to address these issues.

BIOMARKER RESEARCH (2021)

Review Medicine, General & Internal

Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury

Kevin K. W. Wang et al.

Summary: Traumatic brain injury (TBI) is a major cause of mortality and morbidity across all ages, yet there is no FDA-approved drug for treatment. The heterogeneity and complexity of TBI make accurate assessment and prediction challenging. Biomarkers such as ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein have been identified to improve diagnostic accuracy, especially in mild TBI cases.

ACUTE MEDICINE & SURGERY (2021)

Article Clinical Neurology

Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions

Peter Biberthaler et al.

Summary: The study found that GFAP and UCH-L1 are clinically useful biomarkers for ruling out CT-positive injury in acute TBI, and they have excellent differentiation between mild and moderate/severe TBI groups.

NEUROTRAUMA REPORTS (2021)

Article Medicine, General & Internal

High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis

Andrea Sturchio et al.

Summary: The study found that high soluble Aβ42 levels are associated with normal cognition and hippocampal volume despite increasing brain amyloidosis, suggesting that preserving high soluble Aβ42 levels could be important for maintaining cognitive function and hippocampal health.

ECLINICALMEDICINE (2021)

Article Clinical Neurology

Blood Biomarkers Relate to Cognitive Performance Years after Traumatic Brain Injury in Service Members and Veterans

Sara M. Lippa et al.

Summary: This study found that serum UCH-L1 and GFAP may predict cognitive outcomes following complicated mild and more severe TBI, with unexpected correlations in the injured control group.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2021)

Article Clinical Neurology

Elevated Tau in Military Personnel Relates to Chronic Symptoms Following Traumatic Brain Injury

Cassandra L. Pattinson et al.

JOURNAL OF HEAD TRAUMA REHABILITATION (2020)

Article Biochemical Research Methods

QMEANDisCo-distance constraints applied on model quality estimation

Gabriel Studer et al.

BIOINFORMATICS (2020)

Article Critical Care Medicine

Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury

Taylor N. Anderson et al.

JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2020)

Review Clinical Neurology

Blood neurofilament light: a critical review of its application to neurologic disease

Christian Barro et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Article Neurosciences

GFAP at 50

Albee Messing et al.

ASN NEURO (2020)

Review Clinical Neurology

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Editorial Material Clinical Neurology

Biomarkers for traumatic brain injury

Ronak Ved et al.

JOURNAL OF NEUROLOGY (2018)

Article Neurosciences

Tau Kinetics in Neurons and the Human Central Nervous System

Chihiro Sato et al.

NEURON (2018)

Article Biochemistry & Molecular Biology

SWISS-MODEL: homology modelling of protein structures and complexes

Andrew Waterhouse et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Multidisciplinary Sciences

Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls

Massimo S. Fiandaca et al.

PLOS ONE (2018)

Review Psychiatry

Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders

Antonio L. Teixeira et al.

FRONTIERS IN PSYCHIATRY (2018)

Review Medicine, Research & Experimental

The current state of biomarkers of mild traumatic brain injury

Han Jun Kim et al.

JCI INSIGHT (2018)

Article Biochemistry & Molecular Biology

The SWISS-MODEL Repository-new features and functionality

Stefan Bienert et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Clinical Neurology

Predictors of Major Depression and Posttraumatic Stress Disorder Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis

Maryse C. Cnossen et al.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)

Article Cell Biology

Neurofilaments and Neurofilament Proteins in Health and Disease

Aidong Yuan et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Article Multidisciplinary Sciences

CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease

Jonathan D. Cherry et al.

PLOS ONE (2017)

Article Multidisciplinary Sciences

Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology

Martino Bertoni et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Isoelectric Point Separations of Peptides and Proteins

Melissa R. Pergande et al.

PROTEOMES (2017)

Article Biochemistry & Molecular Biology

Amyloid-beta and tau pathology following repetitive mild traumatic brain injury

George Edwards et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Review Biochemistry & Molecular Biology

Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction

Paul Bishop et al.

BIOCHEMICAL JOURNAL (2016)

Article Neurosciences

Current status of fluid biomarkers in mild traumatic brain injury

Jacqueline R. Kulbe et al.

EXPERIMENTAL NEUROLOGY (2016)

Review Behavioral Sciences

Blood biomarkers for brain injury: What are we measuring?

Keisuke Kawata et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)

Article Cell Biology

Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction

James S. Meabon et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Multidisciplinary Sciences

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Pashtun Shahim et al.

SCIENTIFIC REPORTS (2016)

Article Neurosciences

Biomarkers of Traumatic Injury Are Transported from Brain to Blood via the Glymphatic System

Benjamin A. Plog et al.

JOURNAL OF NEUROSCIENCE (2015)

Article Biochemical Research Methods

Modeling and Classification of Kinetic Patterns of Dynamic Metabolic Biomarkers in Physical Activity

Marc Breit et al.

PLOS COMPUTATIONAL BIOLOGY (2015)

Review Neurosciences

The axonal cytoskeleton: from organization to function

Josta T. Kevenaar et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)

Review Physiology

The neurovascular unit - concept review

V. Muoio et al.

ACTA PHYSIOLOGICA (2014)

Article Pharmacology & Pharmacy

Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder

Elizabeth E. Van Voorhees et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)

Review Neurosciences

Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease

Ricardo Cabezas et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2014)

Article Neurosciences

Biomarkers for the Clinical Differential Diagnosis in Traumatic Brain Injury-A Systematic Review

Shoji Yokobori et al.

CNS Neuroscience & Therapeutics (2013)

Article Critical Care Medicine

S100b as a Prognostic Biomarker in Outcome Prediction for Patients with Severe Traumatic Brain Injury

Akash Goyal et al.

JOURNAL OF NEUROTRAUMA (2013)

Article Critical Care Medicine

Brain Injury Biomarkers May Improve the Predictive Power of the IMPACT Outcome Calculator

Endre Czeiter et al.

JOURNAL OF NEUROTRAUMA (2012)

Article Medicine, Research & Experimental

Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration

Eva-Maria Mandelkow et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Correction Radiology, Nuclear Medicine & Medical Imaging

Quantitative measurement of blood brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping (vol 65, pg 1036, 2011)

S. Taheri et al.

MAGNETIC RESONANCE IN MEDICINE (2011)

Article Endocrinology & Metabolism

Ascorbic acid prevents blood-brain barrier disruption and sensory deficit caused by sustained compression of primary somatosensory cortex

Jia-Li Lin et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)

Article Critical Care Medicine

Temporal Profile of Thrombogenesis in the Cerebral Microcirculation after Traumatic Brain Injury in Mice

Susanne M. Schwarzmaier et al.

JOURNAL OF NEUROTRAUMA (2010)

Article Critical Care Medicine

A Panel of Neuron-Enriched Proteins as Markers for Traumatic Brain Injury in Humans

Robert Siman et al.

JOURNAL OF NEUROTRAUMA (2009)

Article Multidisciplinary Sciences

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Azeb Tadesse Argaw et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Clinical Neurology

Glial and neuronal damage markers in patients with anorexia nervosa

Stefan Ehrlich et al.

JOURNAL OF NEURAL TRANSMISSION (2008)

Article Biochemistry & Molecular Biology

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling

Gerty Schreibelt et al.

FASEB JOURNAL (2007)

Review Neurosciences

Astrocyte-endothelial interactions at the blood-brain barrier

NJ Abbott et al.

NATURE REVIEWS NEUROSCIENCE (2006)

Article Neurosciences

Programmed Axon Death, Synaptic Dysfunction and the Ubiquitin Proteasome System

M. P. Coleman et al.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)

Review Anatomy & Morphology

S100B in brain damage and neurodegeneration

M Rothermundt et al.

MICROSCOPY RESEARCH AND TECHNIQUE (2003)

Article Cardiac & Cardiovascular Systems

The no-reflow phenomenon: basic science and clinical correlates

T Reffelmann et al.

HEART (2002)

Article Neurosciences

4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier

K Mertsch et al.

NEUROSCIENCE LETTERS (2001)

Article Clinical Neurology

Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo

JA Hainfellner et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)

Article Cardiac & Cardiovascular Systems

The coronary no-reflow phenomenon: a review of mechanisms and therapies

E Eeckhout et al.

EUROPEAN HEART JOURNAL (2001)